[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Wound Treatments - Vietnam

May 2010 | 30 pages | ID: W96F4BB0DD4EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Wound treatments recorded current retail value growth of 7% in 2009, with sales reaching VND78 billion. Growth was in-line with that recorded in recent years and there are currently no alternatives for such products. Growth during 2009 was mainly fuelled by Vietnam’s increasing population and the fact that such products are relatively affordable for the majority of Vietnamese consumers.

Euromonitor International's Wound Treatments Products in Vietnam report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Other Wound Treatments, Sticking Plasters

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Wound Treatments in Vietnam
Euromonitor International
May 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Sales of Consumer Healthcare Products Increased During 2009
Drug Prices Increase During 2009
Competition Increases Between Domestic and Foreign Players
Drugstores Dominate Distribution Sales
Stable Consumer Healthcare Growth Projected for Forecast Period
Key Trends and Developments
Increasingly Strict Price Controls
Rising Consumer Purchasing Power
Rising Competition Between Domestic and Foreign Producers
Rising Demand for Self Medication and Vitamin and Dietary Supplements
Domestic Companies Strive To Improve Competitive Edge
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self Medication/self-care and Preventative Medicine
Generics
Switches
Definitions
Sector and Subsector Definitions
  Summary 1 Research Sources
Domesco - Dongthap Medical Import Export Corp
Strategic Direction
Key Facts
  Summary 2 Domesco - Dongthap Medical Import Export Corp: Key Facts
  Summary 3 Domesco - Dongthap Medical Import Export Corp: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 4 Domesco - Dongthap Medical Import Export Corp: Competitive Position 2009
Haugiang Pharmaceutical Joint Stock Co
Strategic Direction
Key Facts
  Summary 5 Haugiang Pharmaceutical Joint Stock Co: Key Facts
  Summary 6 Haugiang Pharmaceutical Joint Stock Co: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 7 Haugiang Pharmaceutical Joint Stock Co: Competitive Position 2009
Mekophar Chemical Pharmaceutical Jsc (mekophar)
Strategic Direction
Key Facts
  Summary 8 Mekophar Chemical Pharmaceutical JSC: Key Facts
  Summary 9 Mekophar Chemical Pharmaceutical JSC: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 10 Mekophar Chemical Pharmaceutical JSC: Competitive Position 2009
Pharbaco - Central Pharmaceutical Factory No 1
Strategic Direction
Key Facts
  Summary 11 Pharbaco - Central Pharmaceutical Factory No 1: Key Facts
  Summary 12 Pharbaco - Central Pharmaceutical Factory No 1: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 13 Pharbaco - Central Pharmaceutical Factory No 1: Competitive Position 2009
Traphaco Joint Stock Co
Strategic Direction
Key Facts
  Summary 14 Traphaco Joint Stock Co: Key Facts
  Summary 15 Traphaco Joint Stock Co: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 16 Traphaco Joint Stock Co: Competitive Position 2009
Trends
Category Data
  Table 11 Sales of Wound Treatments by Subsector: Value 2004-2009
  Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
  Table 13 Wound Treatments Company Shares by Value 2005-2009
  Table 14 Wound Treatments Brand Shares by Value 2006-2009
  Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
  Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014


More Publications